Advancing Healthcare in Uzbekistan: BGI Genomics CEO's Vision Shared on Uzbekistan's National Television
HONG KONG, March 15, 2024 /PRNewswire/ -- Zhao Lijian, CEO of BGI Genomics, provided fresh insights on the company's vision during an exclusive interview withUzbekistan's National Television on Channel O'zbekiston24. This discussion was part of the "Focusing on the History of Uzbekistan-China Rel...
Uniting for Women's Wellness on IWD - From China to Uzbekistan
- Interviewing Wang Leilei, the first blind model in China, and Viktoriya Tsay, head of Prenatal and Neonatal Medicine Department at Genscreen, BGI Genomics JV laboratory inUzbekistan. HONG KONG, March 8, 2024 /PRNewswire/ -- To mark International Women's Day (IWD), BGI Genomics interviewed Wang...
Davos Communications Awards - BGI Genomics Inclusive Instagram Strategy Wins Gold Recognition
HONG KONG, Dec. 22, 2023 /PRNewswire/ -- BGI Genomics, the world's leading provider of integrated solutions for precision medicine, is pleased to announce winning Instagram Campaign (Gold) recognition at the Davos Communications Awards held onDecember 12, 2023. Organized by the World Communicati...
Awareness, Accessibility, and Affordability are Crucial for the Early Detection of Thalassemia
- Dr. Zhiyu Peng, Deputy GM at BGI Genomics, Head of the World Hemoglobinopathy Foundation, and Dr.Androulla Eleftheriou, Executive Director at TIF, analyze findings from the Global 2023 State of Thalassemia Awareness Report BANGKOK, Nov. 30, 2023 /PRNewswire/ -- Thalassemia, a hereditary hemogl...
Bridging the Healthcare Gap in Thailand and Beyond with the Belt and Road Initiative
BANGKOK, Oct. 18, 2023 /PRNewswire/ -- "I have a dream that everyone should have the ability to access medical care equally," says Oraphan Wanacharoen (Ice), BGI Genomics Field Application Scientist. "It's very challenging to achieve such a goal inThailand. With the advanced technology of the com...
61.6 percent of Young Thai Women Put off by Pap Smears: BGI Genomics Cervical Cancer Survey
* 61.6% of Thai women aged 21-25 years deterred by pap smears which is higher
than the global average of 43.5% HONG KONG, July 28, 2023 /PRNewswire/ -- Only
28.5% of Thai women are diagnosed at stage I of cervical cancer when survival
rates are highest, according to a study
BGI Genomics Global Cervical Cancer Survey Finds Young Women Have Higher Vaccination Rates but 43.5 percent Put off by Pap Smears
* Vaccination and Screening Form a Virtuous Cycle to Combat Cervical Cancer HONG KONG, July 24, 2023 /PRNewswire/ -- To further inform action to combat cervical cancer, the fourth most common cancer among women globally, BGI Genomics released its State of Cervical Cancer Awareness Report today....
BGI Genomics obtains BSI ISO 37301 Compliance Management System Certification
HONG KONG, June 30, 2023 /PRNewswire/ -- As businesses become increasingly global, changes are happening at an extraordinary pace. Compliance is critical for large economies, industry regulations, and enterprise operations. BGI Genomics prioritizes compliance management and strictly follows law...
BGI Global Colorectal Cancer Survey Reveals Awareness Gaps and Affordability Concerns
HONG KONG, April 7, 2023 /PRNewswire/ -- To uncover attitudes and the biggest challenges facing colorectal cancer (CRC) awareness and screening, BGI Genomics today released its State of Colorectal Cancer Awareness Report, marking the first-ever global survey report on the world's third most commo...
WHO visit photos unveiled - BGI Genomics supports post-pandemic recovery in Hong Kong
SHENZHEN, China, June 15, 2022 /PRNewswire/ -- World Health Organization (WHO) has recently unveiled photos from its Feb-Mar 2021 visit to Hong Kong as COVID-19 affected the city, covering community testing facilities in key locations such as the Hong Kong International Airport and the Morse Park...
BGI safeguards Ethiopia-China Route with airport COVID-19 testing lab
SHENZHEN, China, Sept. 3, 2021 /PRNewswire/ -- From April to August, 2021, BGI's COVID-19 testing lab has helped 5,500 Chinese travelers safely fly out of the Addis Ababa Bole International Airport. In April, BGI set up the "Huo-Yan" laboratory, a COVID-19 testing lab, at the airport for pass...
BGI Statement in Response to Reuters Report
SHENZHEN, China, July 9, 2021 /PRNewswire/ -- BGI is aware of reports in Reuters regarding the company's non-invasive prenatal test (NIPT test) - NIFTY (Non-Invasive Fetal TrisomY). BGI's NIPT tests have been used around the world to identify genetic conditions in pregnancy. These tests provide ...
BGI's Real-time Fluorescent RT-PCR Kit for Detecting 2019-nCoV eligible for WHO Emergency Use Listing
SHENZHEN, China, May 11, 2020 /PRNewswire/ -- BGI Genomics announced that its Real-time fluorescent RT-PCR kit for detecting 2019-nCoV has been listed as eligible for World Health Organization (WHO) procurement under the WHO Emergency Use Listing (EUL) process. The EUL is a risk-based procedure...
BGI Genomics Announces Pricing of Initial Public Offering
SHENZHEN, China, July 14, 2017 /PRNewswire/ -- BGI Genomics, an independent
division of BGI Group, today announced pricing of its initial public offering
of 40.1 million shares at a list price ofRMB 13.64 per share.
